Angel Pellicer - Premios Atlántico de Investigación del Cáncer
PREMIOS ATLÁNTICO 
  DE INVESTIGACIÓN DEL CÁNCER
  2002 – I Conferencia Atlántica del Cáncer
  
  
 
  
ÁNGEL PELLICER 
  Tarragona, 1946 

Catedrático de Bioquímica
  Universidad de Nueva York

Publicaciones Recientes:
1. Perez de Castro I, Bivona TG, Philips 
  MR, Pellicer A. 
  Ras activation in Jurkat T cells following low-grade stimulation 
  of the T-cell receptor is specific to N-Ras and occurs only 
  on the Golgi apparatus.
  Mol Cell Biol. 2004 Apr;24(8):3485-96. 
2. Gao J, Huang HY, Pak J, Cheng J, Zhang 
  ZT, Shapiro E, Pellicer A, Sun TT, Wu XR. 
  p53 deficiency provokes urothelial proliferation and synergizes 
  with activated Ha-ras in promoting urothelial tumorigenesis.
  Oncogene. 2004 Jan 22;23(3):687-96. 
3. Tseng JC, Levin B, Hurtado A, Yee H, 
  Perez de Castro I, Jimenez M, Shamamian P, Jin R, Novick RP, 
  Pellicer A, Meruelo D. 
  Systemic tumor targeting and killing by Sindbis viral vectors.
  Nat Biotechnol. 2004 Jan;22(1):70-7.
4. Diaz R, Lopez-Barcons L, Ahn D, Garcia-Espana 
  A, Yoon A, Matthews J, Mangues R, Perez-Soler R, Pellicer 
  A. 
  Complex effects of Ras proto-oncogenes in tumorigenesis.
  Carcinogenesis. 2004 Apr;25(4):535-9. Epub 2003 Nov 21. 
5. Corral T, Jimenez M, Hernandez-Munoz 
  I, Perez de Castro I, Pellicer A. NF1 modulates the effects 
  of Ras oncogenes: evidence of other NF1 function besides its 
  GAP activity.
  J Cell Physiol. 2003 Nov;197(2):214-24. 
6. Hernandez-Munoz I, Benet M, Calero M, 
  Jimenez M, Diaz R, Pellicer A. rgr oncogene: activation by 
  elimination of translational controls and mislocalization.
  Cancer Res. 2003 Jul 15;63(14):4188-95. 
7. Bivona TG, Perez De Castro I, Ahearn 
  IM, Grana TM, Chiu VK, Lockyer PJ, Cullen PJ, Pellicer A, 
  Cox AD, Philips MR. 
  Phospholipase Cgamma activates Ras on the Golgi apparatus 
  by means of RasGRP1.
  Nature. 2003 Aug 7;424(6949):694-8.
8. de Castro IP, Diaz R, Malumbres M, Hernandez 
  MI, Jagirdar J, Jimenez M, Ahn D, Pellicer A. 
  Mice deficient for N-ras: impaired antiviral immune response 
  and T-cell function.
  Cancer Res. 2003 Apr 1;63(7):1615-22. 
9. Matallanas D, Arozarena I, Berciano 
  MT, Aaronson DS, Pellicer A, Lafarga M, Crespo P. 
  Differences on the inhibitory specificities of H-Ras, K-Ras, 
  and N-Ras (N17) dominant negative mutants are related to their 
  membrane microlocalization.
  J Biol Chem. 2003 Feb 14;278(7):4572-81. 
10. Diaz R, Ahn D, Lopez-Barcons L, Malumbres 
  M, Perez de Castro I, Lue J, Ferrer-Miralles N, Mangues R, 
  Tsong J, Garcia R, Perez-Soler R, Pellicer A. 
  The N-ras proto-oncogene can suppress the malignant phenotype 
  in the presence or absence of its oncogene.
  Cancer Res. 2002 Aug 1;62(15):4514-8. 
11. Leonardi P, Kassin E, Hernandez-Munoz 
  I, Diaz R, Inghirami G, Pellicer A. 
  Human rgr: transforming activity and alteration in T-cell 
  malignancies.
  Oncogene. 2002 Aug 1;21(33):5108-16. 
12. Cheng J, Huang H, Zhang ZT, Shapiro 
  E, Pellicer A, Sun TT, Wu XR. 
  Overexpression of epidermal growth factor receptor in urothelium 
  elicits urothelial hyperplasia and promotes bladder tumor 
  growth.
  Cancer Res. 2002 Jul 15;62(14):4157-63. 
13. Zhang ZT, Pak J, Huang HY, Shapiro 
  E, Sun TT, Pellicer A, Wu XR. 
  Role of Ha-ras activation in superficial papillary pathway 
  of urothelial tumor formation.
  Oncogene. 2001 Apr 12;20(16):1973-80. 
14. Hernandez-Munoz I, Malumbres M, Leonardi 
  P, Pellicer A. 
  The Rgr oncogene (homologous to RalGDS) induces transformation 
  and gene expression by activating Ras, Ral and Rho mediated 
  pathways.
  Oncogene. 2000 May 25;19(23):2745-57. 
15. Melendez B, Malumbres M, de Castro 
  IP, Santos J, Pellicer A, Fernandez-Piqueras J. 
  Characterization of the murine p19(ARF) promoter CpG island 
  and its methylation pattern in primary lymphomas.
  Carcinogenesis. 2000 Apr;21(4):817-21. 
16. Malumbres M, Perez De Castro I, Hernandez 
  MI, Jimenez M, Corral T, Pellicer A. 
  Cellular response to oncogenic ras involves induction of the 
  Cdk4 and Cdk6 inhibitor p15(INK4b).
  Mol Cell Biol. 2000 Apr;20(8):2915-25. 
17. Garcia-Espana A, Biria S, Malumbres 
  M, Levin B, Meruelo D, Pellicer A. 
  Targeted gene transfer system using a streptavidin-transforming 
  growth factor-alpha chimeric protein.
  DNA Cell Biol. 1999 Oct;18(10):743-9. 
18. Perez de Castro IP, Malumbres M, Santos 
  J, Pellicer A, Fernandez-Piqueras J. Cooperative alterations 
  of Rb pathway regulators in mouse primary T cell lymphomas.
  Carcinogenesis. 1999 Sep;20(9):1675-82.
  
  19. Malumbres M, Perez de Castro I, Santos J, Fernandez Piqueras 
  J, Pellicer A. Hypermethylation of the cell cycle inhibitor 
  p15INK4b 3'-untranslated region interferes with its transcriptional 
  regulation in primary lymphomas.
  Oncogene. 1999 Jan 14;18(2):385-96. 
20. Mangues R, Corral T, Lu S, Symmans 
  WF, Liu L, Pellicer A. 
  NF1 inactivation cooperates with N-ras in in vivo lymphogenesis 
  activating Erk by a mechanism independent of its Ras-GTPase 
  accelerating activity.
  Oncogene. 1998 Oct 1;17(13):1705-16. 
21. Corominas M, Kamino H, Leon J, Pellicer 
  A. 
  Oncogene activation in human benign tumors of the skin (keratoacanthomas): 
  is HRAS involved in differentiation as well as proliferation?
  Proc Natl Acad Sci U S A. 1989 Aug;86(16):6372-6.
22. Guerrero I, Villasante A, Corces V, 
  Pellicer A. 
  Loss of the normal N-ras allele in a mouse thymic lymphoma 
  induced by a chemical carcinogen.
  Proc Natl Acad Sci U S A. 1985 Dec;82(23):7810-4. 
23. Guerrero I, Villasante A, Corces V, 
  Pellicer A. 
  Activation of a c-K-ras oncogene by somatic mutation in mouse 
  lymphomas induced by gamma radiation.
  Science. 1984 Sep 14;225(4667):1159-62. 
24. Guerrero I, Villasante A, D'Eustachio 
  P, Pellicer A. 
  Isolation, characterization, and chromosome assignment of 
  mouse N-ras gene from carcinogen-induced thymic lymphoma.
  Science. 1984 Sep 7;225(4666):1041-3. 
25. Guerrero I, Calzada P, Mayer A, Pellicer 
  A. 
  A molecular approach to leukemogenesis: mouse lymphomas contain 
  an activated c-ras oncogene.
  Proc Natl Acad Sci U S A. 1984 Jan;81(1):202-5. 
26. Pellicer A, Robins D, Wold B, Sweet 
  R, Jackson J, Lowy I, Roberts JM, Sim GK, Silverstein S, Axel 
  R. 
  Altering genotype and phenotype by DNA-mediated gene transfer.
  Science. 1980 Sep 19;209(4463):1414-22. 
27. Pellicer A, Wigler M, Axel R, Silverstein 
  S. Related Articles, Links 
  The transfer and stable integration of the HSV thymidine kinase 
  gene into mouse cells.
  Cell. 1978 May;14(1):133-41.